Global pharmaceutical giant, Lupin Limited, has made a significant stride in healthcare innovation with the launch of its state-of-the-art Regional Reference Laboratory in Chennai, Tamil Nadu. This pivotal expansion aligns with Lupin Diagnostics’ commitment to offering accessible, affordable, and high-quality diagnostic healthcare services in South India. The Chennai facility joins Lupin Diagnostics’ extensive network, which now includes 36 laboratories and over 600 collection centers nationwide.

The new Regional Reference Laboratory in Chennai is a beacon of advanced diagnostic technology, staffed by a team of highly qualified clinical experts. Lupin Diagnostics prides itself on offering a wide array of reliable and high-quality diagnostic services. These services range from molecular diagnostics, cytogenetics, and flow cytometry to cytology, microbiology, serology, haematology, immunology, routine biochemistry, and specialized tests, catering to diverse healthcare needs.

In the current healthcare landscape, where evidence-based treatment is paramount, diagnostic tests are critical, influencing nearly 70% of treatment decisions. Adhering to stringent quality control protocols, Lupin Diagnostics ensures the utmost accuracy and integrity of each test. The lab’s temperature-controlled sample movement and robust home collection service, complete with real-time tracking of phlebotomists, place a strong emphasis on patient convenience and reliability.

Ravindra Kumar, CEO of Lupin Diagnostics, emphasized the significance of the Chennai lab: “The launch of our state-of-the-art Regional Reference Laboratory in Chennai signifies a significant step toward accessible and reliable healthcare. Our vision extends beyond lab tests; it encompasses a commitment to empowering doctors and patients through precise, evidence-based diagnostics. With cutting-edge technology and a dedicated team, we aim to redefine healthcare experiences, fostering a society where accurate diagnosis is a cornerstone of well-being.”

Underpinning Lupin Diagnostics’ commitment to excellence are the prestigious NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditations it has achieved. Remarkably, within just two years of operation, 30% of its laboratories (10 laboratories) have attained NABL accreditation, showcasing the company’s unwavering dedication to quality and trust.

This expansion in Chennai not only enhances Lupin’s diagnostic capabilities but also reflects the company’s relentless dedication towards patient-centric healthcare. By integrating advanced technologies and expert services, Lupin Diagnostics is setting a new benchmark in healthcare, making accurate and reliable diagnostics a key pillar in the journey towards healthier lives in India.

  Chennai, India, Lupin, Lupin Diagnostics, Ravindra Kumar, Tamil Nadu